Quantcast
Last updated on April 23, 2014 at 13:36 EDT

Latest Unilife Corporation Stories

2013-04-09 08:29:57

15-Year Contract Expected to Generate up to $110 Million, with Revenue Starting Immediately YORK, Pa., April 9, 2013 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS) today announced the signing of a Customization and Commercial Supply Agreement with a U.S. pharmaceutical company (the "Customer") for the EZMix((TM)) dual-chamber syringe. (Photo: http://photos.prnewswire.com/prnh/20130409/NY91030 ) Unilife will supply the Customer with a...

2013-02-11 16:27:40

YORK, Pa., Feb. 11, 2013 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS), a developer and supplier of injectable drug delivery systems, today announced its financial results for the quarter ended December 31, 2012, (the second quarter of Fiscal Year 2013). Highlights for the Fiscal Year 2013 Second Quarter: In November 2012, Unilife announced that its platform of bolus injection devices had been selected by a global pharmaceutical company to enter a...

2013-02-11 12:25:05

YORK, Pa., Feb. 11, 2013 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS), a U.S. based designer, developer and supplier of injectable drug delivery systems, today announced it will exhibit at the Pharmapack Europe Annual Meeting in Paris, France between February 13(th) and 14(th). "Unilife is delighted to be attending Pharmapack Europe in Paris this week in association with more than 3,000 other pharmaceutical and drug delivery industry leaders,"...

2013-02-11 08:27:18

YORK, Pa., Feb. 11, 2013 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS), a developer and commercial supplier of injectable drug delivery systems, today announced that it has completed the sale of common stock and warrants (the "Units") for gross proceeds of $10 million under a registered direct public offering (the "Offering") with Crede CG II, Ltd., a wholly-owned subsidiary of Crede Capital Group, LLC ("CCG"), a U.S. based accredited, institutional...

2013-02-06 16:26:47

YORK, Pa., Feb. 6, 2013 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS) announced today that it intends to release its financial results for the fiscal 2013 second quarter ended December 31, 2012 after market trading ends on Monday, February 11, 2013. Management has scheduled a conference call for 4:30 p.m. U.S. EST on Monday, February 11, 2013 (Tuesday, February 12, 2013 at 8:30 a.m. AEDT), to review the Company's financial results, market trends, and...

2012-12-19 08:25:15

YORK, Pa., Dec. 19, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS) today announced that another U.S. based pharmaceutical company has commenced stability and evaluation studies of the Unifill syringe for use with multiple injectable drugs. The target drugs, which include both pipeline drugs as well as commercially approved drugs that will benefit from lifecycle extension, are high-value therapeutics for chronic diseases and require...

2012-11-30 12:25:08

YORK, Pa., Nov. 30, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS; ASX: UNS) today announced that all four of the proposed items for its 2012 Annual General Meeting of shareholders were approved by the Company's shareholders. The Company has posted a complete audio archive of the meeting, along with the slide show presentation and a speech from Unilife CEO Mr. Alan Shortall focusing on the Company's commercial pipeline on its website at...

2012-11-12 08:27:39

YORK, Pa., Nov. 12, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS), today announced that it will be presenting at the Lazard 9(th) Annual Healthcare Conference in New York City. Alan Shortall, Chief Executive Officer of Unilife, is scheduled to present at 2:30 p.m. EST on Tuesday, November 13, 2012. The conference presentation will be broadcast over the Internet as a "live" listen only Webcast. To listen, please go to:...

2012-11-08 16:28:28

YORK, Pa., Nov. 8, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS) today announced financial results for the quarter ended September 30, 2012, (the first quarter of Fiscal Year 2013). Recent Highlights: The continued expansion of the Unilife proprietary portfolio of innovative, differentiated device technologies with the addition of the LISA Reusable Auto-Injector, the Unilife Depot-Ject(TM) platform for implanting a drug depot and the Unilife...

2012-11-08 12:28:22

YORK, Pa., Nov. 8, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS; ASX: UNS) today announced that its Precision-Therapy(TM) platform of bolus injection systems has been selected by a global pharmaceutical company to enter the next stage of collaboration as its preferred choice for long-duration subcutaneous drug delivery. Unilife has been advised that the global pharmaceutical company (the "Customer") is targeting more than five pipeline injectable drugs...